StonvexLoading…
StonvexStonvexStonvexCore line items from TISI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $215.06M | $896.48M | $671.66M | $446.68M |
Operating Income | $-3.37M | $14.07M | $7.44M | $6.10M |
Net Income | $-11.33M | $-49.21M | $-45.43M | $-4.27M |
EPS (Diluted) | $-3.12 | $-11.70 | $-10.24 | $-7.56 |
Total Assets | $479.41M | $485.45M | $531.05M | $548.36M |
Total Liabilities | $464.00M | $457.98M | $499.06M | $571.28M |
Cash & Equivalents | $12.84M | $18.14M | $14.81M | $20.71M |
Free Cash Flow OCF − CapEx | $-11.52M | $-20.64M | $-35.28M | $-36.32M |
Shares Outstanding | 4.57M | 4.53M | 4.50M | 4.50M |